The FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications by rss feed | May 5, 2021 | News Feeds CN Bio today announced the U.S. Food and Drug Administration (FDA) has extended their research collaboration, for a further three years. Read Original Copy